Public Company News

CATL and ZEEKR sign five-year strategic cooperation agreement, first volume of Qilin batteries to power ZEEKR models

NINGDE, China, Aug. 29, 2022 /PRNewswire/ -- On August 27, CATL and ZEEKR jointly announced ZEEKR as the first car brand to be powered by mass-produced Qilin batteries. ZEEKR 009 will be the world's first car with Qilin inside, and ZEEKR 001 will be the world's first model equipped with Qilin bat...

2022-08-29 15:48 6129

Össur Acquires Naked Prosthetics

HÄMEENLINNA, Finland, Aug. 29, 2022 /PRNewswire/ -- Össur has acquired Naked Prosthetics, a leading provider of durable, custom and functional finger prostheses for finger and partial hand amputees, with effect from26 August 2022 . The mechanical devices are individually designed to mimic the natu...

2022-08-29 15:32 2707

Halla Group Changes Corporate Name to HL ("Higher Life") Group in Celebration of 60th Anniversary

HL Group paving a new path with its leading affiliates HL Holdings, HL Mando and HL D&I Halla  "Youthfulness is the call of our time. We will take a bold leap forward with our new young brands," said HL Group ChairmanChung Mong-won SEOUL, South Korea, Aug. 29, 2022 /PRNewswire/ -- In celebration ...

2022-08-29 15:00 5421

Recbio Announces Interim results for the Fiscal Year 2022 and Company Progress

* The nine-valent HPV vaccine and other blockbuster varieties have been advanced efficiently. * Cash reserve was nearly RMB 1.5 billion, which provided support to sustainable innovation and commercialization. * The novel adjuvants vaccine will create a strong growth engine. TAIZHOU, China, ...

2022-08-29 13:08 4945

Fosun International Listed in Forbes 2022 China ESG 50

HONG KONG, Aug. 29, 2022 /PRNewswire/ -- Forbes China recently released its "2022 China ESG 50" list. Fosun International has been included on the list for its outstanding ESG performance and its active contribution to the fight against the COVID-19 pandemic.Forbes China pointed out that ESG is s...

2022-08-29 12:52 4894

Porton Advanced and Kun Tuo Announce Strategic Partnership to Deepen Gene and Cell Therapy CDMO and Clinical Research Services

SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- On August 20, 2022, Porton Advanced Solutions (hereinafter referred to as "Porton Advanced") and Kun Tuo Medical Research and Development (Beijing) Co., Ltd. (hereinafter referred to as "Kun Tuo") established a strategic partnership in gene and cell th...

2022-08-29 12:26 2568

Porton Advanced and Royaltech Announce Strategic Collaboration to Accelerate the Development of Bacterial Drugs and mRNA Drugs

SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- On August 19, 2022, Porton Advanced Solutions. (hereinafter referred to as Porton Advanced) announced a strategic cooperation with Suzhou Royaltech Med Co., Ltd. (hereinafter referred to as Suzhou Royaltech).This strategic collaboration will further in...

2022-08-29 12:23 2717

Forrester Announces Full Conference Agenda For B2B Summit APAC 2022

The in-person and digital event will provide the latest research, insights, and best practices to help B2B marketing leaders drive revenue growth SINGAPORE, Aug. 29, 2022 /PRNewswire/ -- Forrester  (Nasdaq: FORR) today announced the full conference agenda for B2B Summit...

2022-08-29 11:12 4020

Fosun International Enters into Strategic Cooperation Agreement with HSBC China

HONG KONG, Aug. 29, 2022 /PRNewswire/ -- Fosun International Limited ("Fosun International", stock code: 00656.HK) and HSBC Bank (China) Company Limited ("HSBC China") renewed a strategic cooperation agreement (the "Agreement") today to provide strong support for Fosun International and its subsi...

2022-08-29 10:59 4112

CPIC's Insurance Business Revenue Growth in 1H 2022 hit a New High in The Past Three Years

Operating Profit Attributable to the Parent Company Increased by 9.9% YOY HONG KONG, Aug. 29, 2022 /PRNewswire/ -- CPIC(601601.SH 2601.HK CPIC.LSE)released its 2022 interim results today. In the first half of 2022, in the face of various challenges, CPIC took the initiative to overcome the diffi...

2022-08-29 08:42 3592

MinterEllison Forecasted to Save 42,000 Legal Team Hours Using Appian

SYDNEY, Aug. 29, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that MinterEllison, one ofAustralia's largest law firms, has automated its business process management system on theAppian Low-Code Platform. MinterEllison, which has 3,000+ partners and staff servicing government, priva...

2022-08-29 07:00 4504

ProSomnus® Sleep Technologies Announces Signing of Definitive Agreements for $30 Million of Convertible Notes

Financing will support Company's pending business combination and fund strategic growth initiatives SAN FRANCISCO, Aug. 26, 2022 /PRNewswire/ -- ProSomnus Sleep Technologies ("ProSomnus"), the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today a...

2022-08-27 04:30 8711

Ascentage Pharma Announces 2022 Interim Results

SUZHOU, China and ROCKVILLE, Md. , Aug. 26, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its 2022 interim results. During the reporting p...

2022-08-27 00:47 15644

Gotion High-tech's Revenue is 8.638 billion with overseas revenue growth of 358.28% in the first half of the year

HEFEI, China, Aug. 26, 2022 /PRNewswire/ -- On August 26 Beijing Time, Gotion High-tech announced its interim results. During the Reporting Period, the Company achieved revenue ofRMB 8,638 million, representing a year-on-year growth of 143.24%, of which revenue from overseas regions increased by ...

2022-08-26 22:28 9837

Ocumension Releases its 2022 Interim Report with its core product Youshiying® being approved for marketing, continuously accelerating product commercialization

BEIJING, Aug. 26, 2022 /PRNewswire/ -- On August 26, 2022 (Beijing time), Ocumension Therapeutics (1477.HK) released its 2022 interim report. The Company's overall performance remained remarkable despite the fact that the pandemic caused considerable trouble in commercializing its ophthalmic prod...

2022-08-26 22:09 13041

Waterdrop Releases User Family Insurance Report

BEIJING, Aug. 26, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently releasedthe User Family Security Report. According to the survey of the users...

2022-08-26 22:00 8601

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

GAITHERSBURG, Md. and SUZHOU, China, Aug. 26, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the advancement of its GalAhead™ RNAi delivery platform f...

2022-08-26 21:54 11063

LONGi Records a 44% YoY Increase in Revenue in H1 2022

XI'AN, China, Aug, 26, 2022 /PRNewswire/ -- In the H1 of 2022, LONGi's operating performance increased steadily, achieving a consolidated operating revenue of50.417 billion yuan, a year-on-year increase of 43.64%. The net profit attributable to the shareholders of the listed company was6.481 bill...

2022-08-26 21:11 7880

New Hope Service Announces 2022 Interim Results

Revenue Achieves High-quality Growth of 27.1%    GFA Under Property Management Increases by 76.4% HONG KONG, Aug. 26, 2022 /PRNewswire/ -- New Hope Service Holdings Limited (" NewHope Service" or "the Company", stock code: 3658.HK ), a well-established comprehensive property management and lifes...

2022-08-26 20:50 13577

First approval of Cadonilimab (PD-1/CTLA-4 bispecific) published in Drugs, a peer-reviewed medical journal

HONG KONG, Aug. 26, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso"), a biopharmaceutical company committed to the research, development, manufacturing and commercialization of either first-in-class or best-in-class therapies, announced a review article featuring onCadonilimab, a first-in-cla...

2022-08-26 20:00 3770